tetano
Editor, Senior Moderator
Emerg Microbes Infect. 2020 Apr 2:1-14. doi: 10.1080/22221751.2020.1750307. [Epub ahead of print]
Diagnostic Value and Key Features of Computed Tomography in Coronavirus Disease 2019.
Li B[SUP]1[/SUP], Li X[SUP]1[/SUP], Wang Y[SUP]1[/SUP], Han Y[SUP]1[/SUP], Wang Y[SUP]1[/SUP], Wang C[SUP]1[/SUP], Zhang G[SUP]2[/SUP], Jin J[SUP]2[/SUP], Jia H[SUP]2[/SUP], Fan F[SUP]2[/SUP], Ma W[SUP]1[/SUP], Liu H[SUP]2[/SUP], Zhou Y[SUP]3[/SUP].
Author information
Abstract
On 31 December 2019, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, Hubei province, China, and caused the outbreak of the Coronavirus Disease 2019 (COVID-19). To date, computed tomography (CT) findings have been recommended as major evidence for the clinical diagnosis of COVID-19 in Hubei, China. This review focuses on the imaging characteristics and changes throughout the disease course in patients with COVID-19 in order to provide some help for clinicians. Typical CT findings included bilateral ground-glass opacity, pulmonary consolidation, and prominent distribution in the posterior and peripheral parts of the lungs. This review also provides a comparison between COVID-19 and other diseases that have similar CT findings. Since most patients with COVID-19 infection share typical imaging features, radiological examinations have an irreplaceable role in screening, diagnosis and monitoring treatment effects in clinical practice.
KEYWORDS:
Computed Tomography; Coronavirus Disease 2019; Diagnosis; SARS-CoV-2
PMID:32241244DOI:10.1080/22221751.2020.1750307
Diagnostic Value and Key Features of Computed Tomography in Coronavirus Disease 2019.
Li B[SUP]1[/SUP], Li X[SUP]1[/SUP], Wang Y[SUP]1[/SUP], Han Y[SUP]1[/SUP], Wang Y[SUP]1[/SUP], Wang C[SUP]1[/SUP], Zhang G[SUP]2[/SUP], Jin J[SUP]2[/SUP], Jia H[SUP]2[/SUP], Fan F[SUP]2[/SUP], Ma W[SUP]1[/SUP], Liu H[SUP]2[/SUP], Zhou Y[SUP]3[/SUP].
Author information
Abstract
On 31 December 2019, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, Hubei province, China, and caused the outbreak of the Coronavirus Disease 2019 (COVID-19). To date, computed tomography (CT) findings have been recommended as major evidence for the clinical diagnosis of COVID-19 in Hubei, China. This review focuses on the imaging characteristics and changes throughout the disease course in patients with COVID-19 in order to provide some help for clinicians. Typical CT findings included bilateral ground-glass opacity, pulmonary consolidation, and prominent distribution in the posterior and peripheral parts of the lungs. This review also provides a comparison between COVID-19 and other diseases that have similar CT findings. Since most patients with COVID-19 infection share typical imaging features, radiological examinations have an irreplaceable role in screening, diagnosis and monitoring treatment effects in clinical practice.
KEYWORDS:
Computed Tomography; Coronavirus Disease 2019; Diagnosis; SARS-CoV-2
PMID:32241244DOI:10.1080/22221751.2020.1750307